Introduction {#sec1-1}
============

Cryptococcosis is an acute, subacute or chronic fungal infection caused by encapsulated heterobasidiomycetous yeast like fungus *Cryptococcus neoformans*. Till date five serotypes have been described. Serotypes A, D and AD hybrids are globally responsible for 98% of all cryptococcal infections in AIDS patients, whereas serotypes B and C predominantly affect immunocompetent individuals, but also have been recently reported in AIDS patients.\[[@ref1][@ref2]\]

Cryptococcal meningitis is a fatal opportunistic neuroinfection and an AIDS defining illness seen in up to 69% of HIV-positive patients.\[[@ref3]\] It can also occur in non-HIV patients who are immunodefecient due to chronic glucocorticoid use, organ transplantation, malignancy and sarcodiosis.\[[@ref4]\] It is a rapidly fatal infection which requires early diagnosis and prompt treatment.

With the advent of antiretroviral therapy, the incidence of cryptococcosis has shown a steady decline in developed countries\[[@ref5]\] when compared with developing where access to anti-retroviral therapy and other necessary healthcare resources are a major limitation.

The incidence of cryptococcal meningitis in India has risen dramatically over the past 20 years.\[[@ref3]\] However, there is paucity of literature on cryptococcosis from the state of Uttarakhand. This study was undertaken to evaluate the prevalence and clinical presentation of cryptococcal meningitis in patients who presented to a tertiary care teaching hospital.

Materials and Methods {#sec1-2}
=====================

A cross-sectional study was conducted in a tertiary care hospital located in Rishikesh, Uttarakhand with a study period of 6 months starting from July to December 2018. CSF samples of 364 patients were received by Microbiology laboratory during this period for the purpose of aerobic bacterial, fungal and TB culture, respectively. All samples were subjected to examination by direct wet mount, Gram stain and India ink preparation. Ziehl Neelsen staining, solid culture for *Mycobacterium tuberculosis* on Lowenstein Jensen medium and Gene Xpert was also performed on all CSF samples. These samples were further subjected to fungal culture on Sabouraud\'s dextrose agar. Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry (MALDI-TOF-MS) (Bruker Biotyper Microflex, MA, USA) was used for identifying all bacterial (except *M. tuberculosis*) and fungal isolates.

Results {#sec1-3}
=======

Out of 364 CSF samples received, 288 were sterile after 48 hours of aerobic incubation. Bacterial isolates, *M. tuberculosis* and *Cryptococcus spp*. were obtained in culture from 51, 21 and 4 samples, respectively. The bacterial profile of 51 CSF samples has been depicted in [Table 1](#T1){ref-type="table"}.

###### 

Microbiological profile of CSF samples

  Organisms identified       Total (%)
  -------------------------- -----------
  *Acinetobacter spp.*       21 (41.1)
  CONS                       13 (25.5)
  *Pseudomonas aeruginosa*   07 (13.7)
  *Staphylococcus aureus*    07 (13.7)
  *Klebsiella pneumoniae*    05 (9.8)
  Total                      51 (100)

The prevalence of cryptococcal meningitis in our study was 1.09% (4/364). *Cryptococcus neoformans var grubii* was the most common isolate (2/4; 50%) followed by *Cryptococcus neoformans var neoformans* (1/4; 25%) and *Cryptococcus neoformans var gattii* (1/4; 25%), respectively. Out of four laboratory-confirmed cryptococcal meningitis patients, 3 (75%) were HIV positive. Clinical and laboratory profile of these patients has been shown in [Table 2](#T2){ref-type="table"}. Gram stain, India ink and culture findings of these patients have been depicted in Figures [1](#F1){ref-type="fig"}--[3](#F3){ref-type="fig"}, respectively.

###### 

Clinical and laboratory profile of cryptococcal meningitis patients

  Patient/age, Sex   Risk factor   Clinical presentation                                                               Sample   Microcopy-Wet mount and India ink   Organism-isolated confidence interval (MALDI-TOF)   Other OIs   Treatment                                              Outcome
  ------------------ ------------- ----------------------------------------------------------------------------------- -------- ----------------------------------- --------------------------------------------------- ----------- ------------------------------------------------------ ----------
  66 year, M         HIV           Fever×7 days Headache×3 days Breathing difficulty×3 days Altered sensorium×3 days   CSF      Budding yeast cell with capsule     *Cryptococcus neoformans var grubii* (2.01)         PTB         Liposomal Amphotericin B                               Expired
  60 years, M        HIV           Headache×1 month Altered sensorium×1 week Seizure 1 episode                         CSF      Budding yeast cell with capsule     *Cryptococcus neoformans var grubii* (2.11)         \_          Liposomal Amphotericin B + Fluconazole + Flucytosine   Survived
  44 year, F         HIV           Headache×2 months Fever×10 days Cough×10 days Decreased vision×10 days              CSF      Budding yeast cell with capsule     *Cryptococcus neoformans var neoformans* (2.24)     \_          Liposomal Amphotericin B + Fluconazole + Flucytosine   Expired
  32 years, M        \-            Headache×4 months Seizure episodes since 2008                                       CSF      Budding yeast cell with capsule     *Cryptococcus neoformans var gattii* (2.35)         \_          Liposomal Amphotericin B + Flucytosine                 Survived

![Gram stain showing budding yeast cells](JFMPC-8-2008-g001){#F1}
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![SDA tube showing mucoid, creamy pasty colonies of *Cryptococcus spp*.](JFMPC-8-2008-g003){#F3}

Discussion {#sec1-4}
==========

The genus *Cryptococcus* contains at least 39 species, but only few are able to cause disease in human beings. Most human infections are caused by *C. neoformans*. The portal of entry is via inhalation of airborne particles, with bird droppings and associated soil being major environmental source following which it frequently pitches itself in the meninges, lungs, bones, adrenals, kidneys, liver and spleen.

The clinical presentation of this disease is variable and therefore difficult to differentiate from other multisystem aliments such as tuberculosis, other tropical infections and malignancies. The most common presenting complaint in our study was headache (100%) which is in concordance with other studies from India.\[[@ref6][@ref7]\] Fever (50%), altered sensorium (25%) and seizure history (25%) were next in line, similar to a study by Abhilash *et al.* (75%, 40% and 18%, respectively).\[[@ref6]\]

Current identification methods for yeasts rely heavily on physical characteristics and biochemical properties of the isolate. Rapid tests such as India ink are often used to quickly and presumptively identify the *Cryptococcus spp*. But even experienced observers can confuse the halo around cells (suggestive of capsule) with artifacts produced by reactions between leukocytes and carbon particle in the India ink stain. For these limitations, rapid tests must be confirmed by additional methods. We used MALDI-TOF-MS to identify all our clinical isolates which is known to have very high sensitivity and specificity. It also allows rapid identification of microbes, which in turn guides the clinicians in early initiation of appropriate therapy, thereby reducing overall time and cost of care. All the four isolates generated confidence scores of more than 2.0 which is considered to be secure species level identification.\[[@ref8]\]

There has been a substantial increase in reporting of cryptococcosis in both immunosuppressed and immunocompetent individuals in recent years, which reflects an enhanced clinical awareness and improved diagnostic capability.

To the best of our knowledge, there is only one case report on cryptococcal meningitis from the state of Uttarakhand by Patil *et al.*\[[@ref9]\] Ours is the first cross-sectional study on prevalence and clinical profile of cryptococcal meningitis from the state of Uttarakhand. Cumulative records of cryptococcal meningitis from India and rest of the world have been depicted in Tables [3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}, respectively.

###### 

Cumulative records of cryptococcal meningitis from different parts of India

  Part of India   No of confirmed cases   No of immunosuppressed cases (%)   Name of Author
  --------------- ----------------------- ---------------------------------- -------------------------------
  East India      16                      16 (100)                           Dash *et al.*\[[@ref10]\]
  16              14 (87)                 Lungram *et al.*\[[@ref11]\]       
  North India     40                      17 (42)                            Kumar *et al.*\[[@ref12]\]
  06              06 (100)                Thakur *et al.*\[[@ref13]\]        
  South India     117                     102 (87)                           Abhilash *et al.*\[[@ref7]\]
  39              39 (100)                Laxmi *et al.*\[[@ref14]\]         
  97              88 (91)                 Naik *et al.*\[[@ref15]\]          
  27              27 (100)                Patel *et al.*\[[@ref16]\]         
  West India      19                      19 (100)                           Baradkar *et al.*\[[@ref17]\]
                  16                      16 (100)                           Kadam *et al.*\[[@ref18]\]

###### 

Cumulative records of cryptococcal meningitis from different parts of world

  Part of world   Total no of confirmed cases   Total no of immunosuppressed cases (%)   Name of Author
  --------------- ----------------------------- ---------------------------------------- -----------------------------
  Taiwan          219                           54 (25)                                  Tseng *et al.*\[[@ref19]\]
  Vietnam         34                            00 (0)                                   Chau *et al.*\[[@ref20]\]
  Brazil          129                           111 (86)                                 Nunes *et al.*\[[@ref21]\]
  Argentina       06                            06 (100)                                 Frola *et al.*\[[@ref22]\]
  Nepal           15                            09 (60)                                  Kharel *et al.*\[[@ref23]\]

Conclusion {#sec1-5}
==========

Cryptococcal meningitis is a rapidly fatal condition which requires a high index of suspicion and calls for a collective effort from family physicians and diagnosticians alike. This disease is under-reported from Uttarakhand and therefore calls for further research from this region.
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